Professionals 443 results
- Gregory A. McConnell
- Chief Pro Bono Officer
- +1 214-453-6474
- vCard
Chief Pro Bono Officer
Capabilities 30 results
Practice Area
Region
Practice Area
Product Liability & Mass Torts
Experience 60 results
Experience
|July 9, 2025
BitMine Completes $20 Billion Upsize of ATM Program
Experience
|July 1, 2025
Experience
|January 31, 2025
Winston Secures Complete Defense Judgment for Alphatec in Prolonged Litigation Battle
Insights & News 1,785 results
In the Media
|March 11, 2026
|2 Min Read
Shan Haider Joins Winston & Strawn in New York
In the Media
|March 10, 2026
|1 Min Read
Eva Davis Profiled as a Trailblazer in M&A by Mergermarket
Client Alert
|March 9, 2026
|3 Min Read
On January 27, 2026, the U.S. Department of Health and Human Services Office of Inspector General (the OIG) issued a Special Advisory Bulletin (the Bulletin) addressing the application of the federal anti-kickback statute (the AKS) to direct-to-consumer (DTC) prescription drug sales.
The Bulletin, the OIG’s first Special Advisory Bulletin since September 2014, was issued in response to the proliferation of DTC programs. The Bulletin, which sets forth the framework under which a manufacturer’s DTC program presents a low risk of violating the AKS, is viewed by the growing DTC industry as favorable guidance. DTC programs offering modern weight-loss medications, such as GLP-1 drugs, are becoming increasingly popular, and the Bulletin provides a helpful framework to support the viability of these programs.
Other Results 36 results
Site Content
Site Content
What Are Pro Forma Financial Statements?
Law Glossary
What Is Corporate Social Responsibility (CSR)?


